Breaking News

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

August 7, 2026
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026
FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
Introduction The Food and Drug Administration maintains high regulatory oversight across all regulated sectors. Quality assurance leaders must evaluate field inspection patterns to keep manufacturing facilities compliant. This detailed fda form 483 summary breaks down major citation drivers, reg...
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026

Features

Home

Home

May 26, 2025
The United States and European Union will be able to use each other’s Pharmaceutical Inspections

The United States and European Union will be able to use each other’s Pharmaceutical Inspections

May 26, 2025
US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.

US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.

May 26, 2025
US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue

US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue

May 26, 2025

Sectors

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026

Services

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
Introduction The Food and Drug Administration maintains high regulatory oversight across all regulated sectors. Quality assurance leaders must evaluate field inspection patterns to keep manufactur...
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026
How FDA Uses AI and Data Analytics During Modern Inspections

How FDA Uses AI and Data Analytics During Modern Inspections

May 17, 2026

News & Trends

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
Introduction The Food and Drug Administration maintains high regulatory oversight across all regulated sectors. Quality assurance leaders must evaluate field inspection patterns to keep manufacturing facilities compliant. This detailed fda form 4...
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026
How FDA Uses AI and Data Analytics During Modern Inspections

How FDA Uses AI and Data Analytics During Modern Inspections

May 17, 2026
The Most Common FDA 483 Observations in Pharmaceutical Manufacturing

The Most Common FDA 483 Observations in Pharmaceutical Manufacturing

May 17, 2026
How FDA Inspects Viral Vector Manufacturing Facilities

How FDA Inspects Viral Vector Manufacturing Facilities

May 17, 2026

Innovation

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
Introduction The Food and Drug Administration maintains high regulatory oversight across all regulated sectors. Quality assurance leaders must evaluate field inspection patterns to keep manufacturing facilities compliant. This detailed fda form 4...
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026
How FDA Uses AI and Data Analytics During Modern Inspections

How FDA Uses AI and Data Analytics During Modern Inspections

May 17, 2026
The Most Common FDA 483 Observations in Pharmaceutical Manufacturing

The Most Common FDA 483 Observations in Pharmaceutical Manufacturing

May 17, 2026
How FDA Inspects Viral Vector Manufacturing Facilities

How FDA Inspects Viral Vector Manufacturing Facilities

May 17, 2026

Company Insight

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
Introduction The Food and Drug Administration maintains high regulatory oversight across all regulated sectors. Quality assurance leaders must evaluate field inspection patterns to keep manufactur...
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026
How FDA Uses AI and Data Analytics During Modern Inspections

How FDA Uses AI and Data Analytics During Modern Inspections

May 17, 2026

Events

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
Introduction The Food and Drug Administration maintains high regulatory oversight across all regulated sectors. Quality assurance leaders must evaluate field inspection patterns to keep manufactur...
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026
How FDA Uses AI and Data Analytics During Modern Inspections

How FDA Uses AI and Data Analytics During Modern Inspections

May 17, 2026

Videos and Webinars

Home

Home

May 26, 20250
The United States and European Union will be able to use each other’s Pharmaceutical Inspections

The United States and European Union will be able to use each other’s Pharmaceutical Inspections

May 26, 20250
US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.

US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.

May 26, 20250
US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue

US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue

May 26, 20250

Sponsored

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026

Innovation

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Form 483 Summary: Latest Trends & Compliance Drivers

FDA Inspections TeamAugust 7, 20260
FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026
What Happens During an FDA For-Cause Inspection?

What Happens During an FDA For-Cause Inspection?

May 17, 2026
FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026
How FDA Uses AI and Data Analytics During Modern Inspections

How FDA Uses AI and Data Analytics During Modern Inspections

May 17, 2026